Laboratory Considerations for Clinical Trials
Science:Life Sciences
In this episode, Alex Watt, Global Head for Biotech Integrated Laboratory Solutions and Alan Wookey, Global Head of Companion Diagnostics discuss how to manage both scientific and operational risk in clinical trials for biotech companies.
Looking at risk as uncertainty reveals not only threats to project timelines but also opportunities to take a new approach.
Alex and Alan talk about:
You can learn more at https://q2labsolutions.com/biotech.
What is the Role of Digital Pathology in Clinical Trials
AI in Pathology: Advancements, Challenges, and the Road Ahead
Flow Cytometry as an IVD technology for Companion Diagnostics
Flexible Approaches for Biotech Companies in Clinical Trials
3 Things to Consider in Preparation for Your Biotech Testing or Trial
Hybrid assays: an interview with Barry Jones and Adriane Spytko
Managing Sample Data from Vendors
Automation within an ADME Laboratory
Bioanalytical Automation of Samples
Consent Tracking for Clinical Samples
Tracking Clinical Trial Samples
Avoiding Canceled Tests in Pediatric Samples
Covid Vaccine Testing
Hybrid Assays for Protein Bioanalysis
High Throughput ADME Testing
Liquid Biopsy Collection in Clinical Development Programs
An Next Generation Sequencing Approach to Influenza Vaccine Development
Standardization of Tumor Mutational Burden by Alignment to Reference Standards
Monitoring the Tumor Micro-environment with Flow Cytometry - Mark Edinger
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Stuff To Blow Your Mind
Terrace | تراس